These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 37500797

  • 21. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL, Sun HF, Gao SP, Li LD, Hu X, Wu J, Jin W.
    Oncotarget; 2015 Jun 30; 6(18):16352-65. PubMed ID: 25970785
    [Abstract] [Full Text] [Related]

  • 22. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer.
    Song H, Luo Q, Deng X, Ji C, Li D, Munankarmy A, Jian W, Zhao J, Fang L.
    Exp Mol Med; 2019 Nov 20; 51(11):1-13. PubMed ID: 31748508
    [Abstract] [Full Text] [Related]

  • 23. STAT1 Mediates the Transcription of CircIFI30 and Promotes the Progression of Triple-Negative Breast Cancer by Up-Regulating CDCA4.
    Zhang J, Xia S, Liu X, Qi D, He X, Chen D.
    J Environ Pathol Toxicol Oncol; 2022 Nov 20; 41(1):1-13. PubMed ID: 35378000
    [Abstract] [Full Text] [Related]

  • 24. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
    Das K, Paul S, Singh A, Ghosh A, Roy A, Ansari SA, Prasad R, Mukherjee A, Sen P.
    J Biol Chem; 2019 Sep 13; 294(37):13681-13696. PubMed ID: 31341019
    [Abstract] [Full Text] [Related]

  • 25. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
    Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW.
    Breast Cancer Res; 2006 Sep 13; 8(2):R16. PubMed ID: 16563182
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 27. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S, Lee J, Jeon M, Lee JE, Nam SJ.
    Oncotarget; 2016 Jan 12; 7(2):1544-58. PubMed ID: 26637807
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 29. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 30. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y, Wang B, Yan Y, Niu L.
    Environ Toxicol; 2022 Oct 10; 37(10):2398-2411. PubMed ID: 35730485
    [Abstract] [Full Text] [Related]

  • 31. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C, Li X, Fan Q, Liu G, Yin J.
    Aging (Albany NY); 2019 Jul 16; 11(14):4858-4875. PubMed ID: 31310241
    [Abstract] [Full Text] [Related]

  • 32. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y, Ma G, Peng S, Tuo M, Li Y, Qin X, Yu Q, Kuang S, Cheng H, Li J.
    Thorac Cancer; 2021 Sep 16; 12(18):2427-2438. PubMed ID: 34324278
    [Abstract] [Full Text] [Related]

  • 33. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z, Ashour A, Kahraman N, Ozpolat B.
    Oncotarget; 2016 Mar 29; 7(13):16619-35. PubMed ID: 26918606
    [Abstract] [Full Text] [Related]

  • 34. Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity.
    Gao L, Chen S, Hong M, Zhou W, Wang B, Qiu J, Xia J, Zhao P, Fu L, Wang J, Dai Y, Xie N, Yang Q, Huang HD, Gao X, Zou C.
    Signal Transduct Target Ther; 2021 Jul 05; 6(1):250. PubMed ID: 34219129
    [Abstract] [Full Text] [Related]

  • 35. Crucial role of the Rap G protein signal in Notch activation and leukemogenicity of T-cell acute lymphoblastic leukemia.
    Doi K, Imai T, Kressler C, Yagita H, Agata Y, Vooijs M, Hamazaki Y, Inoue J, Minato N.
    Sci Rep; 2015 Jan 23; 5():7978. PubMed ID: 25613394
    [Abstract] [Full Text] [Related]

  • 36. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
    Tang X, Zhou Y, Liu Y, Zhang W, Liu C, Yan C.
    J Cell Biochem; 2020 Nov 23; 121(11):4642-4653. PubMed ID: 32048750
    [Abstract] [Full Text] [Related]

  • 37. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.
    Oncotarget; 2016 Jul 12; 7(28):43124-43149. PubMed ID: 27281609
    [Abstract] [Full Text] [Related]

  • 38. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
    Gong C, Zou J, Zhang M, Zhang J, Xu S, Zhu S, Yang M, Li D, Wang Y, Shi J, Li Y.
    Mol Carcinog; 2019 Oct 12; 58(10):1863-1875. PubMed ID: 31264274
    [Abstract] [Full Text] [Related]

  • 39. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
    Jin XX, Mei YN, Shen Z, Zhu JF, Xing SH, Yang HM, Liang G, Zheng XH.
    Phytomedicine; 2022 Jul 12; 101():154087. PubMed ID: 35429924
    [Abstract] [Full Text] [Related]

  • 40. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
    Huang WC, Chi HC, Tung SL, Chen PM, Shih YC, Huang YC, Chu PY.
    Cells; 2021 Sep 24; 10(10):. PubMed ID: 34685504
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.